Additional Products

aBSI

Learn more

aPROMISE

Learn more

AZEDRA®

Lantheus is discontinuing the production of AZEDRA. Please reach out to the AZEDRA Service Connection at 844-AZEDRA1 (844-293-3721) with any questions. 

Cardiolite®

(Kit for the Preparation of Technetium Tc99m Sestamibi for Injection)

Learn more

NEUROLITE®

(Kit for the Preparation of Technetium Tc 99m Bicisate for Injection)

Learn more

Xenon Xe-133 Gas

Learn more


Our Focus

Market-leading Precision Diagnostics allow clinicians to Find and Follow disease in the earliest stages—when it matters most. And our expertise in Radiopharmaceutical Oncology combines diagnostic and therapeutic products to Find, Fight and Follow® cancers with a high unmet need.

Today, we’re also at the forefront of Digital Imaging Software and Pharma Solutions, with groundbreaking artificial intelligence (AI) technologies that move us toward the future of precision medicine.

Strategic Partnerships are another critical component of our focus on innovation. They’re how we connect and collaborate with like-minded companies, institutions and investors who align with our strategy to deliver precision medicine to patients across the care spectrum.

References:
  1. Key Statistics for Prostate Cancer. American Cancer Society. Published January 12, 2022. Accessed June 21, 2022. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html#:~:text=Prostate%20cancer%20can%20be%20a,Survival%20Rates%20for%20Prostate%20Cancer
  2. Heart Disease Facts. Centers for Disease Control and Prevention. Published February 7, 2022. Accessed June 21, 2022. https://www.cdc.gov/heartdisease/facts.htm

Our Pipeline

Innovation is our continual search for a way to improve patients’ lives.